Cargando…

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

Detalles Bibliográficos
Autores principales:	Peñuelas, Iván, Vugts, Daniëlle J., Decristoforo, Clemens, Elsinga, Philip H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328850/ https://www.ncbi.nlm.nih.gov/pubmed/31659485 http://dx.doi.org/10.1186/s41181-019-0055-6

Ejemplares similares

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
por: Elsinga, Philip, et al.
Publicado: (2010)

Nomenclature for radiopharmaceuticals, consultation of your opinion!
por: Elsinga, Philip H.
Publicado: (2017)

Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
por: Jalilian, Amirreza, et al.
Publicado: (2023)

EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020)

EANM guideline on quality risk management for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2022)

US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
por: Schwarz, Sally W., et al.
Publicado: (2019)

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
por: Koziorowski, J., et al.
Publicado: (2016)

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2021)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

New sensitive method for HEPES quantification in (68)Ga-radiopharmaceuticals
por: Antunes, I. F., et al.
Publicado: (2020)

Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
por: Kolenc Peitl, Petra, et al.
Publicado: (2019)

Position statement on radiopharmaceutical production for clinical trials
por: Bormans, G., et al.
Publicado: (2017)

The present status of radiopharmaceuticals in the country
por: Jalilian, Amir Reza, et al.
Publicado: (2016)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)
por: Al-Qahtani, Mohammed, et al.
Publicado: (2021)

Greetings from the New President of World Association of Radiopharmaceutical and Molecular Therapy
por: Srivastava, Suresh
Publicado: (2016)

Greetings from the New President of the World Association of Radiopharmaceutical and Molecular Therapy
por: Virgolini, Irene
Publicado: (2018)

Metal-Based Radiopharmaceuticals in Inorganic Chemistry
por: Boschi, Alessandra, et al.
Publicado: (2023)

Radiopharmaceutical Formulation and Preclinical Testing of (68)Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
por: Hörmann, Anton A., et al.
Publicado: (2021)

Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
por: Petrik, Milos, et al.
Publicado: (2012)

Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
por: de Vries, E. F. J., et al.
Publicado: (2022)

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality
por: Luurtsema, Gert, et al.
Publicado: (2021)

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
por: Todde, S., et al.
Publicado: (2017)

Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
por: Frank, Christopher, et al.
Publicado: (2019)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy
por: Kopka, Klaus
Publicado: (2014)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
por: Ayesa, Sally L., et al.
Publicado: (2022)

When and how to Screen!
por: Ekbom, A.
Publicado: (2020)

Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
por: Korde, Aruna, et al.
Publicado: (2022)

Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board
por: Aime, Silvio, et al.
Publicado: (2021)

PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials
por: Ramnaraign, Brian, et al.
Publicado: (2023)

Editorial - EJNMMI radiopharmacy and chemistry
por: Elsinga, Philip H.
Publicado: (2016)

EJNMMI Radiopharmacy and Chemistry obtains its first impact factor!!
por: Elsinga, Philip H.
Publicado: (2023)

Randomized Clinical Trials of Artificial Intelligence in Medicine: Why, When, and How?
por: Park, Seong Ho, et al.
Publicado: (2022)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bartoli, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uovhokujqvvu6s9cu0svton24q